DoD Prostate Cancer Exploration Hypothesis Development Award | Apply Online

Opportunity Summary:

The DoD Prostate Cancer Exploration Hypothesis Development Award (Funding Opportunity Number W81XWH-12-PCRP-EHDA) is a U.S. Department of Defense prostate cancer research funding opportunity administered through the Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), under CFDA 12.420 (Military Medical Research and Development). It is designed to push the field toward genuinely new directions by supporting early-stage, high-risk ideas that have not yet been proven. The central goal is to help investigators explore bold concepts and develop hypotheses that could lead to major advances in understanding, preventing, detecting, or treating prostate cancer, even when it is not yet clear whether the approach will succeed. The emphasis is placed squarely on innovation, and the program explicitly recognizes that the eventual impact of these ideas may be hard to forecast at the time of review.

A defining feature of this award is that it targets untested and potentially groundbreaking concepts rather than incremental extensions of established lines of work. In line with that intent, preliminary data are strongly discouraged, signaling that applicants should not feel pressured to present extensive prior results as proof-of-feasibility. Instead, proposals are expected to make a compelling case for why the idea is novel, how it challenges current assumptions or opens a new area of inquiry, and what the logical pathway would be for developing and evaluating the hypothesis. This structure is meant to create space for creative, speculative, and unconventional thinking that might struggle to compete in traditional funding programs that heavily reward prior data and predictable outcomes.

The opportunity allows for human subject research, but only within a limited regulatory scope: human studies are permitted if they qualify as exempt or are eligible for expedited review. In practical terms, this means the program is not aimed at large, complex, high-risk clinical trials or studies requiring full board review with substantial interventions. Rather, it can accommodate lower-risk human subject work, such as certain types of minimal-risk observational studies, secondary analyses, or other designs that meet the criteria for exemption or expedited Institutional Review Board pathways. Applicants considering human subjects would need to ensure that their study design fits those constraints.

Another notable element is the use of blinded review. Both peer reviewers and programmatic reviewers are blinded to the identities of the principal investigator, collaborators, and their institutions. This process is intended to keep the focus on the scientific idea itself and reduce the influence of reputation, institutional prestige, or prior visibility in the field. As a result, the clarity of the written proposal and the strength of the conceptual rationale become especially important, since reviewers evaluate the work without knowing who is behind it.

From an administrative standpoint, this was a discretionary funding opportunity offered through grants and cooperative agreements within the broader Science and Technology and other Research and Development activity category. The program anticipated making about 25 awards, with an estimated total funding level of $3,000,000. The listing indicates no cost sharing or matching requirement, which lowers barriers for participation and allows applicants to propose projects without needing to secure additional non-federal contributions. Eligible applicants were described as unrestricted (open to any type of entity), subject to any clarifications provided in the full announcement text.

Key dates for the archived 2012 cycle include a posted and creation date of March 22, 2012, an original and current closing date of June 20, 2012, and an archive date of July 20, 2012. For assistance accessing the full announcement, the contact provided is the CDMRP Help Desk at 301-682-5507. Overall, the award is best understood as a mechanism to seed radically innovative prostate cancer research directions at the idea and hypothesis-development stage, prioritizing novelty and transformative potential over extensive preliminary evidence, while permitting only limited-scope human subject research and using blinded review to emphasize merit of the concept.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: Youth Environmental Outdoor Education and Camps

Previous opportunity: Arkansas Final CIG

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 12 PCRP EHDA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 12 PCRP EHDA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 12 PCRP EHDA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.